Skip to content

Comparison of clinical efficacy of traditional choledochoscope versus eyeMAX in PTCSL

Comparison of clinical efficacy of traditional choledochoscope versus eyeMAX in PTCSL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097401
Enrollment
Unknown
Registered
2025-02-19
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrahepatic bile duct stones

Interventions

Disposable choledochoscope (eyeMAX Insight) group:none

Sponsors

The Second Affiliated Hospital, Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Intrahepatic bile duct stones were confirmed by CT, MRCP and cholangiography before operation; 2. Age ranges from 18 to 90; 3. The general condition is good, no organic damage and dysfunction of important organs, can tolerate general anesthesia and open surgery; 4. Preoperative liver function Child-Pugh grade A or Child-Pugh grade B; 5. Normal coagulation function; 6. History of at least one previous biliary tract operation; 7. Informed consent of patients and their families.

Exclusion criteria

Exclusion criteria: 1. Patients with organic damage and dysfunction of important organs, unable to tolerate general anesthesia and open surgery; 2. Preoperative liver function Child-Pugh grade C; 3. Abnormal coagulation function; 4. Patients with liver atrophy or intrahepatic bile duct cancer; 5. Patients with acute obstructive suppurative cholangitis requiring emergency surgery; 6. Patients with less than 1 previous biliary tract operation.

Design outcomes

Primary

MeasureTime frame
Rate of stone clearance after first session;stone clearance;Complication rate;

Secondary

MeasureTime frame
Clavien-Dindo grading of postoperative complications;Number of stone access channels;Total operations;Total operating time;Intraoperative blood loss;Postoperative hospital stay;Hospitalization expenses;Stone recurrence rate;mortality rate;

Countries

China

Contacts

Public ContactCheng Yao

The Second Affiliated Hospital, Chongqing Medical University

chengyao1986@hospital.cqmu.edu.cn+86 157 3627 6836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026